Who
Jeegar Pravinkumar Patel
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Evommune.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $826K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Nov 2025
- Last trade
- 22 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code M | $5,7141,488 at $3.84 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Sold | $33K1,488 at $22.50 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,488 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,488 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code M | $5,7141,488 at $3.84 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Sold | $33K1,488 at $22.50 | filing |
| 1 Jun 2026filed 3 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code M | $52K13,512 at $3.84 | filing |
| 1 Jun 2026filed 3 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Sold | $379K16,687 at $22.74 | filing |
| 1 Jun 2026filed 3 Jun 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,512 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,512 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code M | $52K13,512 at $3.84 | filing |
| 1 Jun 2026filed 3 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Sold | $379K16,687 at $22.74 | filing |
| 16 Apr 2026filed 17 Apr 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,315 at $0.00 | filing |
| 16 Apr 2026filed 17 Apr 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,315 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | EVMN EvommuneBiotechnology | SEC FORM 4 Code F | $134K7,513 at $17.84 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code C | —25,000 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN EvommuneBiotechnology | SEC FORM 4 Code C | —3,175 | filing |
| 5 Nov 2025filed 7 Nov 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —179,619 at $0.00 | filing |
News
Evommune (NYSE:EVMN) Stock Bumped Up to "Hold" by UBS GroupEVMN · tickerreport.com · 14 Oct 2026Evommune (NYSE:EVMN) Upgraded at UBS GroupEVMN · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Jeegar Pravinkumar Patel; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.